Actualités et Mises à Jour de Emma Walmsley
Retour au ProfilRecevez les dernières nouvelles, mises à jour et contenus sur Emma Walmsley. Ne manquez aucun potin ou nouveau contenu adulte.
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 million pounds in 2023
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: GlaxoSmithKline CE...
GSK names new CEO to replace Emma Walmsley
Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journa...
GSK CEO Emma Walmsley Says Drugmaker Is ‘Betting Big’ on the US
GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US Pre...
Emma Walmsley
On the C-SPAN Networks: Emma Walmsley is a CEO for the GlaxoSmithKline with one video in the C-SPAN ...
GSK’s boss Emma Walmsley to step down after eight-year tenure
GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley following eight ye...
GSK CEO Emma Walmsley says it's ‘obnoxious’ when CEOs complain about their hard lives
GSK CEO Emma Walmsley has said she finds it “obnoxious” when company leaders complain about how ...
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 mln pounds in 2023
March 1 (Reuters) - GSK (GSK.L), opens new tab CEO Emma Walmsley's total remuneration rose 51% to 12...
GSK CEO Walmsley to step down, be succeeded by company’s commercial lead
Andrew covers the biopharma industry, scientific research, and public health across the continent. Y...
GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million)...
GSK CEO Emma Walmsley to Step Down
GSK GSK-2.07%decrease; red down pointing triangle said Chief Executive Emma Walmsley would step down...
GSK raises 2025 sales forecast after strong growth in specialty medicines
(Reuters) -GSK raised its 2025 sales and earnings expectations on Wednesday after third-quarter resu...
GSK boosted by cancer and HIV drugs as Emma Walmsley bows out
GSK has lifted its sales and profits targets after a boost from HIV and oncology drugs as chief exec...